Position in CDXS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$366,731
+$71,825 QoQ
Shares Held
162,271
-10.3% QoQ
Ownership
0.148%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#41
of 148 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 99%
None 1%
Common Shares in CDXS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $14,420,023,301 across 296 Biotechnology names. CDXS ranks #210 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,043,052 | $3,995,225,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,940,665 | $2,457,162,245 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,754,318 | $1,130,162,341 | |
| 4 | INCY |
Incyte Corp
|
4,080,461 | $462,561,050 | |
| 5 | ARGX |
Argenx SE
|
443,990 | $411,920,598 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
1,671,684 | $409,178,086 | |
| 7 | MRNA |
Moderna, Inc.
|
5,780,299 | $404,794,337 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
1,201,644 | $379,827,645 |
All Filings in CDXS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $366,731 | 162,271 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $294,906 | 180,925 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $284,580 | 174,590 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $300,450 | 123,136 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $234,429 | 96,078 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $181,431 | 67,447 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $160,895 | 33,731 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $102,575 | 33,304 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $95,346 | 30,757 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $342,654 | 98,182 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $108,826 | 35,681 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $71,892 | 38,039 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $95,600 | 34,143 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $137,098 | 33,116 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $144,156 | 30,935 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $177,496 | 29,290 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $273,737 | 26,170 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $554,739 | 26,903 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $842,725 | 26,950 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $746,761 | 32,105 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $610,278 | 26,932 | Shares | Defined | 2021-08-17 | |
| 2021-03-31 | $356,213 | 15,562 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $247,114 | 11,320 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||